Medical Device Manufacturers Are Playing a Critical Role in Addressing the Evolving Needs of Patients in the Esophageal Motility Disorder ...

Hyderabad: Medical device maker Medtronic is looking at options to modify its global manufacturing footprint as part of efforts to mitigate any impact of U.S. President Donald Trump's tariff plans ...

The FDA has approved Medtronic's Brainsense Adaptive deep brain stimulation for patients with Parkinson's disease. The technology is designed to adjust therapy in real time based on a patient's ...

Seventeen years before Medtronic’s recent FDA approval for the world’s first adaptive deep brain ... and then both learn about the physiology effects but also learn about how to design our devices ...

HYDERABAD Feb 25 (Reuters) - Medical device maker Medtronic (MDT.N), opens new tab is looking at options to modify its global manufacturing footprint as part of efforts to mitigate any impact of U ...

Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the FDA’s approval for its adaptive, closed-loop neurostimulation approach ...

(Reuters) – The U.S. Food and Drug Administration has approved Medtronic’s deep brain stimulation system for use in patients with Parkinson’s disease, the medical device maker said on Monday.

Feb 24 (Reuters) - The U.S. Food and Drug Administration has approved Medtronic's (MDT.N), opens new tab deep brain stimulation system for use in patients with Parkinson's disease, the medical ...

Medtronic has received approval from the US Food and Drug Administration (FDA ... respectively. In light of the studies, GlobalData medical device analyst Cynthia Stinchcombe noted that the increasing ...